Effects of Tezepelumab on Quality of Life of Patients with Moderate-to-Severe, Uncontrolled Asthma: Systematic Review and Meta-Analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s11882-023-01085-y.pdf
Reference34 articles.
1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Published 2022. Accessed 18 Nov 2022. https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf.
2. • Edris A, De Feyter S, Maes T, Joos G, Lahousse L. Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis. Respir Res. 2019;20(1):179. https://doi.org/10.1186/s12931-019-1138-3. This article evaluates new biologic agents for persistently uncontrolled asthma and compares their effects on asthma exacerbation rate.
3. •• Pelaia C, Pelaia G, Crimi C, et al. Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. Int J Mol Sci. 2021;22(9). https://doi.org/10.3390/ijms22094369. This article reviews the role of thymic stromal lymphopoietin in the pathogenesis of asthma and the rationale for the use of tezepelumab as an add-on therapy for severe, uncontrolled asthma.
4. Gauvreau GM, Sehmi R, Ambrose CS, Griffiths JM. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert Opin Ther Targets. 2020;24(8):777–92. https://doi.org/10.1080/14728222.2020.1783242.
5. Corren J, Parnes JR, Wang L, et al. Tezepelumab in Adults with Uncontrolled Asthma (PATHWAY). N Engl J Med. 2017;377(10):936–46. https://doi.org/10.1056/NEJMoa1704064.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update;Brazilian Journal of Otorhinolaryngology;2024-01
2. Moderate asthma: burden, mechanisms and therapeutic perspectives;Current Opinion in Allergy & Clinical Immunology;2023-10-25
3. Asthma Phenotypes in the Era of Personalized Medicine;Journal of Clinical Medicine;2023-09-26
4. Effects of Tezepelumab on Quality of Life of Patients with Moderate-to-Severe, Uncontrolled Asthma: Systematic Review and Meta-Analysis;Current Allergy and Asthma Reports;2023-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3